Biotricity Inc. (BTCY) stock
BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 4/30
$0.05+0.00 (+8.70%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Biotricity operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Biotricity's operating cash flow for the twelve months ending Jun 30, 2026 was $161.66K. For fiscal 2026 it was -$718.96K. The highest annual figure on record is -$8.22K in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$718.96K | – |
| FY2025 | Mar 31, 2025 | -$2.38M | – |
| FY2024 | Mar 31, 2024 | -$6.69M | – |
| FY2023 | Mar 31, 2023 | -$13.55M | – |
| FY2022 | Mar 31, 2022 | -$15.16M | – |
| FY2021 | Mar 31, 2021 | -$11.08M | – |
| FY2020 | Mar 31, 2020 | -$7.86M | – |
| FY2019 | Mar 31, 2019 | -$5.22M | – |
| FY2018 | Mar 31, 2018 | -$4.87M | – |
| FY2014 | Aug 31, 2014 | -$8.22K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $507.23K | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$20.91K | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$740.29K | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $415.63K | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$373.39K | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$400.79K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$88.09K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$397.06K | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$1.49M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$1.17M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$1.31M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$2.39M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$1.83M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$1.88M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$3.18M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$4.76M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$4.49M | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$3.24M | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$2.68M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$3.58M | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$2.97M | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$2.14M | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$2.39M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$2.95M | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$2.12M | -252.1% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$1.46M | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$1.33M | – |
| Q1 FY2019CQ2 2018 | Dec 31, 2018 | -$4.06M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $1.39M | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$1.64M | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$1.03M | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | -$923.24K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | -$1.28M | – |
| Q4 FY2014CQ3 2014 | Aug 31, 2014 | -$1.48K | – |
See a number that looks wrong?